DIANE BRACKIN: Open Payments
NPI 1730579525 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,215 in 58 payments from 18 companies in 2025. Trend: 2023 $3,553 · 2024 $8,327 · 2025 $1,215
Food & beverage: $1,215
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $312 |
| United Therapeutics Corporation | 2 | $119 |
| Novo Nordisk Inc | 5 | $108 |
| Alnylam Pharmaceuticals Inc. | 4 | $108 |
| Regeneron Healthcare Solutions, Inc. | 5 | $105 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $90 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| Merck Sharp & Dohme LLC | 4 | $75 |
| PFIZER INC. | 3 | $48 |
| Edwards Lifesciences Corporation | 1 | $32 |
Products named: Adempas, Kerendia, AMVUTTRA, EVKEEZA, LifeVest, LEQVIO, VERQUVO, Wegovy.
Industry payments across FL — which companies pay providers there.
